In this randomised , multicenter , open-label , three-way crossover study , patients 18years with adult RA undergoing treatment with MTX for 3months were assigned to receive MTX 10 , 15 , 20 and 25mg weekly in a random sequence of three treatments : oral , SC into the abdomen and SC into the thigh .